Keros Therapeutics Inc. (KROS)
NASDAQ: KROS
· Real-Time Price · USD
14.41
-0.01 (-0.07%)
At close: Aug 15, 2025, 1:31 PM
Keros Therapeutics Fail-to-Deliver
Total FTD Shares
4.96K
Below Average
FTD / Avg. Volume
0.94%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 11, 2025,
Keros Therapeutics Inc. has
4,961
shares failed to deliver, representing 0.94%
of the average daily volume of
530,517
shares. Over the past year, the monthly average FTD is
2,450
shares, with the current level 102% above
the historical average, indicating
elevated
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 11, 2025 | 14.44 | 4.96K | +581.46% |
| Jun 26, 2025 | 13.51 | 728 | +232.42% |
| May 29, 2025 | 14.02 | 219 | +476.32% |
| Apr 28, 2025 | 14.26 | 38 | +31.03% |
| Mar 13, 2025 | 11.47 | 29 | -71.00% |
| Feb 07, 2025 | 10.86 | 100 | -89.88% |
| Jan 30, 2025 | 11.71 | 988 | -99.24% |
| Dec 20, 2024 | 17.03 | 129.8K | +2595900.00% |
| Nov 22, 2024 | 55.92 | 5 | -98.92% |
| Sep 09, 2024 | 53.88 | 461 | +880.85% |
| Aug 30, 2024 | 45.35 | 47 | -45.98% |
| Jul 19, 2024 | 48.38 | 87 | -99.46% |
| Jun 24, 2024 | 46.48 | 16.15K | +32198.00% |
| May 30, 2024 | 46.31 | 50 | -84.42% |
| Apr 25, 2024 | 54.19 | 321 | -32.70% |
| Mar 28, 2024 | 66.2 | 477 | +3307.14% |
| Feb 28, 2024 | 68.07 | 14 | -97.21% |
| Jan 25, 2024 | 56.29 | 501 | -81.66% |
| Dec 29, 2023 | 39.76 | 2.73K | -45.38% |
| Nov 30, 2023 | 30.34 | 5K | +627.80% |
| Oct 30, 2023 | 28.02 | 687 | +816.00% |
| Sep 29, 2023 | 31.88 | 75 | -95.14% |
| Aug 14, 2023 | 35.36 | 1.54K | +225.32% |
| Jul 28, 2023 | 41.97 | 474 | +3.27% |
| Jun 30, 2023 | 40.18 | 459 | +7.49% |
| May 30, 2023 | 48.64 | 427 | +104.31% |
| Apr 25, 2023 | 43.86 | 209 | -90.11% |
| Mar 31, 2023 | 42.7 | 2.11K | +4702.27% |
| Feb 24, 2023 | 53.2 | 44 | -94.55% |
| Jan 30, 2023 | 58.54 | 807 | n/a |